Phosphoramidite Market is estimated to be US$ 2.59 Billion by 2030 with a CAGR of 7.50% during the forecast period

Download Sample

Published Date: May 2023

The phosphoramidite market accounted for US$ 1.26 billion in 2020 and is estimated to be US$ 2.59 billion by 2030 and is anticipated to register a CAGR of 7.50%. A phosphoramidite (RO)2PNR2 is a phosphite diester monoamide. Phosphoramidite chemistry is the industry's gold standard process for DNA synthesis, having been used for nearly 35 years. It is currently the only commercially viable chemistry capable of producing the amount of DNA needed by the synthetic biology industry. Nucleoside phosphoramidites are phosphoramidites derived from secured nucleosides that are commonly used in the chemical synthesis of DNA, RNA, and other nucleic acids and their analogues. In asymmetric synthesis, some phosphoramidites are often used as monodentate chiral ligands. TheraPure RNA phosphoramidites have emerged as the gold standard for developing and producing RNA-based therapeutic oligonucleotides as RNA becomes a key driver of therapeutic technologies.

The report "Global Phosphoramidite Market, By type (DNA-RNA phosphoramidite, speciality phosphoramidite, dye-labeled phosphoramidite and Others), By Modification methods (Base modification, sugar modification and others), By End-user (Molecular Diagnostics, Pharmaceuticals, and life science Research company), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

Antisense oligonucleotides were used by Rosalind Franklin University of Medicine and Science researchers to start a new therapeutic method for treating Batten disease, a fatal neurodegenerative disease in infants, in July 2020.
Innovative Genomic Institute announced in 2020 that they are developing an aerosolized locked nucleic acid modified antisense oligonucleotide that can be inhaled or nebulized for COVID-19 infection treatment.

Analyst View:

Because of their high performance, research institutes and diagnostic centres have shifted their attention to genomics and genetics, which has boosted demand for high-quality synthesised oligonucleotides in the phosphoramidites market in recent years. Phosphoramidites are modified nucleosides that are commonly used in DNA synthesis today. Today, phosphoramidites come in a variety of modified forms, each with properties tailored to particular DNA synthesis processes. Today, phosphoramidites and their modified forms are the gold standard in DNA synthesis.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Phosphoramidite Market, By type (DNA-RNA phosphoramidite, speciality phosphoramidite, dye-labeled phosphoramidite and Others), By Modification methods (Base modification, sugar modification and others), By End-user (Molecular Diagnostics, Pharmaceuticals, and life science Research company), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Market Insights from the report:

The global phosphoramidite market accounted for US$ 1.26 billion in 2020 and is estimated to be US$ 2.59 billion by 2030 and is anticipated to register a CAGR of 7.50%. The Global Phosphoramidite Market is segmented based on type, modification methods, end-user and region.

By type, the Global Phosphoramidite Market is segmented into DNA-RNA phosphoramidite, speciality phosphoramidite, dye-labeled phosphoramidite and Others.
By modification methods, the market is segmented in Base modification, sugar modification and others.
By end-user, the Global Phosphoramidite Market is segmented into Molecular Diagnostics, Pharmaceuticals, and life science Research company.
By region, the Global Chemotherapy induced acral erythema (Hand foot syndrome) treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape:

The key players operating in the global phosphoramidite market includes Thermo Fisher Scientific, Integrated DNA Technologies, Inc, Sigma-Aldrich Corporation, GE Healthcare, TriLink BioTechnologies, Inc, BioAutomation Corporation, Twist Bioscience, and Shanghai SynTheAll Pharmaceutical Co., Ltd.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning.
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period.